Ryanair Up, Diageo's Tariff Losses, Roche Up

On this episode of Stock Movers:

- Ryanair signaled robust demand for travel this summer, with fares rising and Europeans sticking close to home for their holidays.

- Diageo expects sales growth to improve in the second half of the year and set out a cost-cutting program, as the British distiller grapples with US tariffs on its shipments from the UK and Europe.

- Shares in drug companies Roche and BioArctic may be active in Monday trading after US drug regulators approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find and treat patients.

See omnystudio.com/listener for privacy information.